EUVIMEDTutustu EUVIMEDiin
Open access · CC BY 4.0

Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity

Takeshi Susukida iD, Yuchen Sun iD, Noriaki Arakawa, Takuya Hirao, Tadahaya Mizuno, Shigeki Aoki, Kousei Ito, Yoshihiro Hayakawa

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70385 ↗

At a glance

Journal article in British Journal of Pharmacology, 2026. Written by Takeshi Susukida and 7 co-authors. Institution: Laboratory of Cancer Biology and Immunology, Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama, Toyama, Japan. Major MEDLINE topics: Dideoxynucleosides, Drug Hypersensitivity, CD8-Positive T-Lymphocytes, HLA-B Antigens. 49 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Society for the Promotion of Science, Nakatomi Foundation, Tamura Science and Technology Foundation.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background and Purpose Drug hypersensitivity reactions (DHRs) associated with a specific human leukocyte antigen (HLA) allotype do not manifest uniformly in all individuals within an HLA model population. This scenario highlights the complexity of predicting drug hypersensitivity reaction risk without considering additional factors. Furthermore, conducting prospective clinical studies of drug hypersensitivity reactions in humans is unfeasible. Therefore, this study aimed to prospectively evaluate HLA‐mediated drug hypersensitivity reactions by using a unique transgenic mouse line harbouring HLA‐B*57:01 (B*57:01‐Tg) and performing abacavir‐induced hypersensitivity reactions. Experimental Approach B*57:01‐Tg mice or their littermates were orally administered either an abacavir‐containing or a vehicle‐only diet. Subsequently, analyses were performed on isolated CD8 + T‐cells collected from the lymph nodes, ear biopsies, or plasma of these mice. Key Results RNA sequencing and proteomic data analyses performed on the isolated CD8 + T‐cells demonstrated that the expression levels of several glycolytic enzymes, including hexokinase 2, were significantly up‐regulated in abacavir‐treated B*57:01‐Tg mice. Moreover, the glycolytic rate and metabolite production significantly increased in these mice. Although treatment with the pyruvic acid carrier inhibitor UK5099 did not affect CD8 + T‐cell activation, inhibiting glycolysis using 2‐deoxy‐D‐glucose or diet‐based calorie restriction attenuated the increase in IFN‐γ–secreting effector memory CD8 + T‐cells. Consequently, this attenuation prevented CD8 + T‐cell dermal infiltration in abacavir‐treated B*57:01‐Tg mice. Conclusion and Implications Overall, these results suggest the indispensable role of glycolytic CD8 + T‐cell metabolism in HLA‐mediated abacavir‐induced hypersensitivity reactions, which may further determine susceptibility to HLA‐mediated drug hypersensitivity reactions in humans.

Subjects

MeSH terms (MEDLINE)

DideoxynucleosidesDrug HypersensitivityCD8-Positive T-LymphocytesHLA-B AntigensGlycolysisAnimalsAbacavirMice, TransgenicMiceHumans

Author keywords

abacavir‐induced hypersensitivitydrug hypersensitivity reactionsglycolytic metabolismhuman leukocyte antigenmouse model

Substances

AbacavirDideoxynucleosidesHLA-B AntigensHLA-B*57:01 antigen

Authors and institutions

  • Laboratory of Cancer Biology and Immunology, Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama, Toyama, Japan.
  • Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
  • Divisions of Clinical Pharmacokinetics, Department of Pharmaceutical Sciences, International University of Health and Welfare, Otawara, Tochigi, Japan.
  • Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan.
  • Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan.

ORCID profiles: Takeshi Susukida, Yuchen Sun

Funding

  • Japan Society for the Promotion of Science
  • Nakatomi Foundation
  • Tamura Science and Technology Foundation
  • 2024 Director Leadership Expenses, Institute of Natural Medicine, University of Toyama

Cite

APA

Susukida, T., Sun, Y., Arakawa, N., Hirao, T., Mizuno, T., Aoki, S., Ito, K., & Hayakawa, Y. (2026). Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity. British Journal of Pharmacology. https://doi.org/10.1111/bph.70385

Vancouver

Susukida T, Sun Y, Arakawa N, Hirao T, Mizuno T, Aoki S, et al. Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity. British Journal of Pharmacology. 2026. doi:10.1111/bph.70385

BibTeX
@article{Susukida2026,
  author = {Susukida, Takeshi and Sun, Yuchen and Arakawa, Noriaki and Hirao, Takuya and Mizuno, Tadahaya and Aoki, Shigeki and Ito, Kousei and Hayakawa, Yoshihiro},
  title = {Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70385}
}
Start for free →